HIV treatment as prevention: modelling the cost of antiretroviral treatment--state of the art and future directions.
Policy discussions about the feasibility of massively scaling up antiretroviral therapy (ART) to reduce HIV transmission and incidence hinge on accurately projecting the cost of such scale-up in comparison to the benefits from reduced HIV incidence and mortality.We review the available literature on modelled estimates of the cost of providing ART t